Why the study?
Practice patterns and outcomes of medical devices postapproval may differ by country, motivating a direct comparison of national TAVR registry data between the United States and Japan.
Do patient characteristics and periprocedural outcomes of transcatheter aortic valve replacement differ between the United States and Japan?
Population
244 722 TAVRs from 646 US institutions and 26 673 TAVRs from 171 Japanese institutions
Comparison
TAVR in Japan vs TAVR in the United States
Design
Binational harmonized registry study
Follow-up
30-day
Loading...
TAVR outcomes favor Japan despite higher risk; hypothesis-generating for practice differences and requires prospective validation.
Do patient characteristics and periprocedural outcomes of transcatheter aortic valve replacement differ between the United States and Japan?
Despite being older and having a higher predicted risk of mortality, TAVR patients in Japan had lower 30-day mortality and major morbidity compared to those in the United States, highlighting international practice differences.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: